CordenPharma CEO Transition Herbeaux Quirmbach
Analysis based on 6 articles · First reported Sep 15, 2026 · Last updated Sep 17, 2026
The CEO transition at a private, Astorg-backed CDMO is a routine leadership change with limited direct read-through for public markets, though it signals continuity of CordenPharma's growth and capacity-expansion strategy in the pharmaceutical services sector. Investors in listed CDMO peers and Astorg portfolio watchers may note the appointment of an experienced operator from Hovione as a neutral-to-mildly-positive signal for the company's execution and customer delivery.
CordenPharma, a global pharmaceutical contract development and manufacturing organization (CDMO) backed by private equity firm Astorg, announced the appointment of Dr. Jean-Luc Herbeaux as Chief Executive Officer effective 1 October 2026. Herbeaux succeeds Dr. Michael Quirmbach, who served as CEO since 2019 and spent 12 years with the company, during which CordenPharma grew annual revenue from 245 million euros to more than 1 billion euros. Quirmbach will remain actively involved as a Board Member and Senior Advisor. Herbeaux joins from Hovione, an international CDMO where he was CEO for more than four years and previously COO, and earlier held senior roles at specialty chemicals group Evonik. The transition follows a period of significant expansion, including the acquisition of peptide CDMO AmbioPharm and continued investment in manufacturing capacity. CordenPharma now employs approximately 3,500 people across 13 facilities in Europe, North America and Asia, and reported sales of 960 million euros in the 2025 financial year. Astorg, which acquired CordenPharma in 2022, expressed support for the new leadership, with Co-Managing Partner Judith Charpentier praising Quirmbach's contribution and welcoming Herbeaux's operational and CDMO experience. Herbeaux stated his focus will be disciplined execution of growth plans, deepening customer partnerships and strengthening capabilities.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard